For following the competition: what moved in each program, several studies read as one move.
- recombinant human thrombopoietin
- hetrombopag olamine
- mezagitamab
- + 2 more
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add Thrombocytopenia to watchlistEvery Monday by email · turn it off any timePro · free during the beta